Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Curr Allergy Asthma Rep ; 22(11): 141-150, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36103081

RESUMO

PURPOSEOF REVIEW: The pathogenesis of eosinophilic granulomatosis with polyangiitis (eGPA) is driven largely by CD4 + type 2 helper T cells (Th2), B cells, and eosinophils. Interleukin (IL)-4 and IL-13 are critical cytokines in Th2 cell-mediated inflammation; however, inhibition of IL-4 and IL-13 does not reduce serum eosinophil counts and has even been associated with hypereosinophilia. This review explores the role of IL-4, IL-5, and IL-13 in Th2-mediated inflammation to consider the potential clinical consequences of inhibiting these individual cytokines in eGPA. RECENT FINDINGS: Treatments for eosinophilic granulomatosis with polyangiitis (eGPA) are rapidly evolving through using biologic therapies to modulate the Th2 inflammatory response via eosinophil inhibition. While IL-4, IL-5, IL-13, and IL-25 can all affect eosinophils, only IL-5 inhibition has demonstrated therapeutic benefit to-date. In this review, we report a clinical vignette of a patient with adult-onset asthma who developed severe manifestations of eGPA after switching from mepolizumab (an IL-5 inhibitor) to dupilumab (an inhibitor of IL-4 and IL-13). By understanding the role of IL-4, IL-5, and IL-13 in Th2-mediated vasculitis, we can start to understand how eGPA might respond differently to focused cytokine inhibition.


Assuntos
Síndrome de Churg-Strauss , Granulomatose com Poliangiite , Adulto , Síndrome de Churg-Strauss/complicações , Síndrome de Churg-Strauss/tratamento farmacológico , Citocinas , Granulomatose com Poliangiite/tratamento farmacológico , Humanos , Inflamação , Interleucina-13/uso terapêutico , Interleucina-4/uso terapêutico , Interleucina-5 , Células Th2
2.
J Palliat Med ; 27(9): 1220-1228, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38489603

RESUMO

Palliative care improves outcomes, yet rural residents often lack adequate and equitable access. This study provides practical tips to address palliative care (PC)-related challenges in rural communities. Strategies include engaging trusted community partners, addressing cultural factors, improving pediatric care, utilizing telehealth, networking with rural teams including caregivers, and expanding roles for nurses and advanced practice providers. Despite complex barriers to access, providers can tailor PC to be patient-centered, respect local values, and bridge gaps. The "Top 10" format emphasizes the relevant issues to enable clinicians to provide optimal care for people from rural areas.


Assuntos
Cuidados Paliativos , Serviços de Saúde Rural , Humanos , Estados Unidos , Acessibilidade aos Serviços de Saúde , População Rural , Feminino , Masculino , Adulto , Pessoa de Meia-Idade
3.
J Palliat Med ; 26(9): 1307-1308, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37477651
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA